Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Elelyso (Taliglucerase-alfa).
Allergic reactions: Some people may develop a serious allergic reaction to Elelyso (Taliglucerase-alfa). This reaction can occur up to 24 hours after receiving a dose of taliglucerase alfa. Signs of an allergic reaction include a severe rash, hives, swollen face or throat, or difficulty breathing. If these occur, get immediate medical attention.
Dizziness: Taliglucerase may cause dizziness. Do not drive, operate machinery, or perform other hazardous tasks until you have determined how Elelyso (Taliglucerase-alfa) affects you.
Infusion-related reactions: As with other enzyme therapies, taliglucerase alfa can cause severe infusion-related reactions, including severe allergic reactions. Your health care provider will closely monitor you during and after the infusion, and may give you other medications before you receive the taliglucerase alfa, to prevent these reactions.
If you experience symptoms of an infusion reaction, such as fever, chills, difficulty breathing, tightness of chest or throat, stomach upset, and rash, tell your health care provider immediately. Symptoms can usually be reduced by slowing down or temporarily stopping the medication, as well as using other medications to treat the reaction.
It is important to take the medication(s) recommended by your doctor before your infusion of taliglucerase alfa. If you experience a severe infusion reaction, your doctor will give you additional medications to treat the reaction. Ask your doctor for more information.
Pregnancy: Elelyso (Taliglucerase-alfa) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Elelyso (Taliglucerase-alfa), contact your doctor immediately.
Breast-feeding: It is not known if taliglucerase alfa passes into breast milk. If you are a breast-feeding mother and are taking Elelyso (Taliglucerase-alfa), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Elelyso (Taliglucerase-alfa) have not been established for children less than 2 years old.